Cargando…
Prognostic Biomarkers in Individuals with Prevalent Coronary Heart Disease
Coronary disease is the leading killer of individuals worldwide and a leading cause of healthcare expenditure. On a global scale, ischemic heart disease kills over 6 million individuals each year and is projected by the World Health Organization to be the greatest single-disease cause of death world...
Autores principales: | Halim, Sharif A., Newby, L. Kristin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833693/ https://www.ncbi.nlm.nih.gov/pubmed/19773615 http://dx.doi.org/10.3233/DMA-2009-0645 |
Ejemplares similares
-
Markers of Inflammation and Risk of Coronary Heart Disease
por: Sarwar, Nadeem, et al.
Publicado: (2009) -
Evaluating the Prognostic Value of New Cardiovascular Biomarkers
por: Wood, Angela M., et al.
Publicado: (2009) -
The Stromelysin-1 5A/6A Promoter Polymorphism Is a Disease Marker for the Extent of Coronary Heart Disease
por: Schwarz, Adelheid, et al.
Publicado: (2002) -
Prevalence and prognostic implications of sarcopenia in older patients with coronary heart disease
por: Zhang, Ning, et al.
Publicado: (2019) -
Chromosome 9p21.3 is Associated with Early-Onset Coronary Heart Disease in the Irish Population
por: Meng, Weihua, et al.
Publicado: (2008)